Patented Lumenis Optimal Pulse Technology (OPT) becomes the first IPL approved for management of dry eye disease due to MGD, and Lumenis launches OptiLight.
Yan et al. (2021): The Efficacy of Intense Pulsed Light Combined With Meibomian Gland Expression for the Treatment of Dry Eye Disease Due to Meibomian Gland Dysfunction: A Multicenter, Randomized Controlled Trial
In a prospective, multicenter, randomized control trial, Lumenis IPL with OPT™ combined with MGX significantly improved signs and symptoms of DED due to MGD.
Optilight by Lumenis – A Bright Solution for Dry Eyes- official launch event
Presenting OptiLight, Lumenis revolutionary new light- based treatment for dry eye disease. Dr. Adler hosts Drs. Toyos, Periman and Epstein, plus OptiLight patients
Yang et al. (2021): Treatment of contact lens related dry eye with intense pulsed light
In a prospective paired-eye study of patients wearing contact lenses and experiencing contact lens related dry eye, eyes treated with Lumenis IPL with OPTTM improved in signs and symptoms of dry eye disease (DED).
WesternU College of Optometry Partners With Lumenis for Hands-On Training in Laser Therapy
Western University of Health Sciences College of Optometry partners with Lumenis to train students in Digital Duet, the first digital SLT-YAG and cutting-edge OptiLight treatments.
Laser treatment vs drops
Weighing first-line therapies for glaucoma? Dr. Kristin O. Chapman explains how to answer the question: Should you prescribe drops first or start with SLT?
Diversify Your Practice for Long-term Success
Dr. Nate Lighthizer advises ODs to embrace management of eye diseases such as dry eye and glaucoma. Here are his tips for building a diverse, healthy optometry practice.
SLT Is my Patients “Insurance Policy” COVID-19 just Proved it
With Selecta Duet, Dr. Nate Radcliffe controls IOP without frequent visits and often without medication—two clear advantages during COVID-19 lockdowns.
SLT for Glaucoma with Dr. Nate Lighthizer
In an interactive webinar, Dr. Nate Lighthizer discusses Lumenis SLT’s advantages for glaucoma patients and referral decisions for this trusted laser treatment.
The dropless future: SLT as a first-line treatment for glaucoma
Dr. Kristin O. Chapman explains how SLT’s promotion to first-line therapy is changing the age-old battle for glaucoma drop tolerance and adherence.